Results 101 to 110 of about 4,953 (173)

Waldenström Macroglobulinemia and Cerebral Venous Thrombosis: From Diagnosis to Complication

, 2019
Waldenström macroglobulinemia (WM) is a type of non-Hodgkin lymphoma in which cancer cells produce large amounts of an abnormal protein that can cause hyperviscosity syndrome (HVS). A 43-year-old woman with WM, who developed seizures, had a head computed
Pedro Vieira, Orlando Mendes, Andreia Póvoa, Heidy Cabrera, Céu Evangelista, Pedro Chorão, Paulo Zoé Costa   +6 more
core   +1 more source

An Atypical Case of Relapsing Polychondritis Associated With Waldenström Macroglobulinemia

Annals of Internal Medicine: Clinical Cases
Relapsing polychondritis is a rare disease characterized by relapsing-remitting inflammation of cartilage and has been found to be associated as a paraneoplastic syndrome to hematologic malignancies.
Robin H. Lo, Bavani Nadeswaran
doaj   +1 more source

Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study

, 2019
BACKGROUND: Chemoimmunotherapy is typically the standard of care for patients with Waldenström macroglobulinemia; however, infectious and hematologic toxic effects are problematic.
Minnema, Monique, Owen, Roger G, Iyengar, Sunil, Monique C Minnema (8231724), Kersten, Marie José, Shirley D'Sa (8231709), Daniel Greenwald (8231733), Cheson, Bruce D., Francesco Forconi (517485), Melanie M Frigault (8231739), Roger G Owen (8231706), Minnema, Monique C., Thomas, Sheeba, Walter, Harriet, Frigault, Melanie M., Pier Luigi Zinzani (8231718), Ahmed Hamdy (440993), Furman, Richard R., Thomas, Sheeba K., Frigault, Melanie, Harriet Walter (8231730), Patel, Priti, Sheeba K Thomas (8231712), Mittag, Diana, Diana Mittag (371113), Greenwald, Daniel, Furman, Richard, Minnema, Monique C, Rule, Simon, Marie José Kersten (7296185), Raquel Izumi (3151191), Tournilhac, Olivier, Izumi, Raquel, Aurran-Schleinitz, Thérèse, Olivier Tournilhac (8231715), Lee, Sun Ku, Cheson, Bruce, D'Sa, Shirley, Jaimal Kothari (6078821), Simon Rule (4569193), Owen, Roger G., Kothari, Jaimal, Owen, Roger, Frigault, Melanie M, Zinzani, Pier Luigi, Furman, Richard R, Thomas, Sheeba K, Bruce D Cheson (8207025), Sun Ku Lee (4582915), Priti Patel (183896), Helen Wei (8231742), Chen, Dih-Yih, Efstathios Kastritis (3138102), Cheson, Bruce D, Wei, Helen, Sunil Iyengar (8231721), McCarthy, Helen, Hamdy, Ahmed, Richard R Furman (8231745), Dih-Yih Chen (8231736), Forconi, Francesco, Thérèse Aurran-Schleinitz (8231727), Kastritis, Efstathios, Helen McCarthy (414643)   +63 more
core   +2 more sources

Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia

Haematologica, 2018
Jorge J. Castillo, Joshua N. Gustine, Kirsten Meid, Toni Dubeau, Patricia Severns, Steven P. Treon   +5 more
doaj   +1 more source

Monoclonal antibody-based therapies for Waldenström's macroglobulinemia

, 2022
Monoclonal antibodies have established an important role in the treatment armamentarium of hematological malignancies, including Waldenström's macroglobulinemia.
Fotiou, D., Theodorakakou, F., Kastritis, E.   +2 more
core  

The role of ibrutinib in Waldenström macroglobulinemia

, 2018
Introduction: Waldenström macroglobulinemia (WM) is an uncommon incurable B-cell lymphoma characterized by the presence lymphoplasmacytic cells in the bone marrow.
Gavriatopoulou, Maria, Terpos, Evangelos, Dimopoulos, Meletios Athanasios, Gavriatopoulou, M., Terpos, E., Dimopoulos, M.A., Kastritis, E., Kastritis, Efstathios   +7 more
core  

Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia

, 2023
Apart from the MYD88L265P mutation, extensive information exists on the molecular mechanisms in Waldenström's Macroglobulinemia and its potential utility in the diagnosis and treatment tailoring.
Ferrero, S., Garcia-Sanz, R., Jiménez, C., Drandi, D., Roos-Weil, D., Hou, J., Dimopoulos, M., Li, Y., Castillo, J.J., Hunter, Z.R., Guerrera, M.L., Bagratuni, T., De Larrea, C.F., Owen, R.G., Varettoni, M., Roccaro, A.M., Leiba, M., Qiu, L., San-Miguel, J.F., Poulain, S., McMaster, M., Treon, S.P.   +21 more
core  

High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia

International audienceAbstract Histologic transformation of Waldenström macroglobulinemia (HT-WM) carries a poor prognosis with standard treatments. Here, we report the first series of HT-WM treated with chimeric antigen receptor T cells showing a high ...
Decroocq, Justine, Bensaber, Hedi, Delmer, Alain, Gastinne, Thomas, Roos-Weil, Damien, Bachy, Emmanuel, Cheminant, Morgane, Jacquet, Caroline, Chauchet, Adrien, Houot, Roch, Reshef, Ran, Le Gouill, Steven, Cony-Makhoul, Pascale, Treon, Steven, Gros, François-Xavier, Durot, Eric, Coste, Arthur, Castillo, Jorge, Guidez, Stéphanie, Di Blasi, Roberta   +19 more
core   +1 more source

Waldenström macroglobulinemia – between lymphoma and myeloma

Waldenströmova makroglobulinemija je rijedak indolentni B-stanični limfom koji je karakteriziran prisutnošću monoklonalnog imunoglobulina M u serumu i klonalnom proliferacijom limfoplazmocitoidnih stanica u koštanoj srži.
Galiot, Lucija
core   +2 more sources

Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis

Blood Cancer Journal
Venetoclax showed promising activity in a small phase II trial in relapsed/refractory Waldenström macroglobulinemia (WM). To report the clinical activity of venetoclax and prognostic factors associated with outcomes in a larger cohort, we retrospectively
Y. Sawalha, S. Sarosiek, R. L. Welkie, S. Seif, S. Thapa, S. Zanwar, K. Cahill, R. Treitman, H. Shah, S. Arora, G. Pongas, A. Winter, A. Major, P. A. Riedell, M. L. Palomba, P. Kapoor, A. Grajales-Cruz, K. H. Shain, S. K. Thomas, J. J. Castillo   +19 more
doaj   +1 more source